Delivery of XL184 directly to the tumor site produced these promising results at a dosage level less than one thousandth of what is used in oral therapy, with little or no toxicity.
Oral mystery Despite HPV's role in increasing the number of oropharyngeal cancers, it seems to producetumors that are much easier to treat than HPV - negative malignancies.